Replies to post #2464 on Revive Therapeutics Ltd (RVVTF)

[Bruinfan4ever]

Since they have already laid out the entire trial of up to 800 patients, I would think they already have funding for this. The CEO also said the trial is starting in the fall .

[highvalue]

Nothing makes sense in this industry money flows in on speculation initially one out of 100 of the biotechs make money and their shares skyrocket I am still long on RVV why would they be accelerated to stage 3 without some good science.It is still a long shot but worth risking a few thousand.

[ReikoBlack]

Another example...Humanigen, Inc. (HGEN)

On June 2nd they announced equity financing for their phase III trial.

BOOM! The share price was off to the races.

IMHO, the jump in share price will happen upon the announcement of the company that the FDA has given Revive the green light to proceed with their phase III trials.

I believe the Market is also waiting for Revive to announce that they've secured funding.

Take a look at the chart of CYDY. On March 31st, they announced that the FDA had given them the green light to proceed with phase II trial. Also that same day, in a different PR, CYDY announced that they completed a non-dilutive convertible note financing.

By the way, if you look at the PPS days before their PR announcements you'll see that the share price increased. Someone knew of the pending news.